Press Releases
Boehringer Ingelheim licenses ProBioGen's novel GlymaxX Technology
read more Boehringer Ingelheim licenses ProBioGen's novel GlymaxX Technology
ProBioGen Presents GlymaxX - The Novel Glyco-Engineering Technology
read more ProBioGen Presents GlymaxX - The Novel Glyco-Engineering Technology
ProBioGen Announces the Appointment of Dr. Volker Sandig to Chief Scientific Officer
read more ProBioGen Announces the Appointment of Dr. Volker Sandig to Chief Scientific Officer